Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-29

Clinical Trial Update: Early Levothyroxine Post Radioactive Iodine [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on early levothyroxine after radioactive iodine for Graves' disease reported completion and results posting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Mayo Clinic | Conditions: Graves' Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-10-29